Platelet Isoprostane Overproduction in Diabetic Patients Treated With Aspirin
Open Access
- 14 May 2012
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 61 (6) , 1626-1632
Abstract
Aspirin modestly influences cardiovascular events in patients with type 2 diabetes mellitus (T2DM), but the reason is unclear. The aim of the study was to determine whether in T2DM patients aspirin enhances platelet isoprostanes, which are eicosanoids with proaggregating properties derived from arachidonic acid oxidation by platelet NOX2, the catalytic subunit of reduced NAD phosphate oxidase. A cross-sectional study was performed comparing T2DM patients, treated (n = 50) or not treated (n = 50) with 100 mg/day aspirin, with 100 nondiabetic patients, matched for age, sex, atherosclerosis risk factors, and aspirin treatment. A short-term (7 days) treatment with 100 mg/day aspirin also was performed in 36 aspirin-free diabetic and nondiabetic patients. Higher platelet recruitment, platelet isoprostane, and NOX2 activation was found in diabetic versus nondiabetic patients and in aspirin-treated diabetic patients versus nontreated patients (P < 0.001). Platelet thromboxane (Tx) A2 (P < 0.001) was inhibited in all aspirin-treated patients. In the interventional study, aspirin similarly inhibited platelet TxA2 in diabetic and nondiabetic patients (P < 0.001). Platelet recruitment, isoprostane levels, and NOX2 activation showed a parallel increase in diabetic patients (P < 0.001) and no changes in nondiabetic patients. These findings suggest that in aspirin-treated diabetic patients, oxidative stress–mediated platelet isoprostane overproduction is associated with enhanced platelet recruitment, an effect that mitigates aspirin-mediated TxA2 inhibition.Keywords
This publication has 27 references indexed in Scilit:
- Inherited Human gp91phoxDeficiency Is Associated With Impaired Isoprostane Formation and Platelet DysfunctionArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Oxidative Stress and Diabetic ComplicationsCirculation Research, 2010
- Atorvastatin Inhibits gp91phoxCirculating Levels in Patients With HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Diabetes-Induced Oxidative Stress Is Mediated by Ca2+-Independent Phospholipase A2 in NeutrophilsThe Journal of Immunology, 2010
- Hereditary Deficiency of gp91phoxIs Associated With Enhanced Arterial DilatationCirculation, 2009
- Mechanisms of Increased Vascular Superoxide Production in Human Diabetes MellitusCirculation, 2002
- The way I see it: House officers need formal career developmentBMJ, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- NSAID-Induced Urticaria and AngioedemaAmerican Journal of Clinical Dermatology, 2002
- Mechanisms of platelet activation: Thromboxane A2 as an amplifying signal for other agonistsThe American Journal of Cardiology, 1991